Director of Business Development, Olema Oncology
$190-240k
Therapy development for women's cancers
Job no longer available
Therapy development for women's cancers
101-200 employees
Job no longer available
$190-240k
101-200 employees
Company mission
To develop therapies that offer the potential to improve outcomes for women living with cancer.
Role
Who you are
- 7-10 years of business development experience, required
- Biotech industry experience, required
- Analytical and financial modeling experience, required
- Track record of successfully managing projects and partner programs, required
- Due diligence request experience, preferred
- Running a data room for due diligence activities, preferred
- BA/BS in scientific field or related discipline, required
- MBA from top university program, required
- Well-developed understanding of biotech industry dynamics and current knowledge of the oncology landscape, required
- Knowledge of the drug development process, required
- Experience in oncology therapeutic area, preferred
What the job involves
- Hold a leadership role across all business development activities in partnership with the COO/CFO and CEO
- Manage business development partnership programs (current and potential), including project sourcing, due diligence, financial modeling & projections, and deal negotiations
- Collect, analyze, and report on the competitive landscape and industry trends to inform business strategy
- Develop financial projections, analysis and valuation models for potential corporate collaborations, business plans, and partnerships
- Field and respond to business development inquiries (internally and externally)
- Position the company as a partner of choice to biotech and pharma companies through a variety of interactions and networking
- Assist the COO/CFO in investor outreach, including the creation and presentation of impactful messaging and external communications
- Partner with the internal scientific and clinical teams to better understand the company pipeline and strategic interests
Our take
With the global oncology drug market expected to exceed $390 billion by 2027, there is a massive commercial opportunity in cancer research. Olema Oncology is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women’s cancers.
Olema are leveraging the knowledge of the molecular action of estrogen receptors, designing compounds that should be superior to both current drugs and those in development. It has secured massive amounts of funding to support its monotherapy Phase 3 trial, and will continue to advance research and development across other projects.
Freddie
Company Specialist at Welcome to the Jungle
Insights
142% employee growth in 12 months
Company
Funding (2 rounds)
Jul 2020
$54m
SERIES B
Aug 2018
$6.1m
SERIES A
Total funding: $60.1m
Company benefits
- Annual bonus, and stock equity package
- 401K Match and the option to participate in an Employee Stock Purchase Plan
- Robust health plan for both our employees’ and their dependents’ medical, dental, and vision coverage
- Flexible work model
- Allowances to help with both home office and commute
- Flexible Time Off Vacation package
Company HQ
South Park, San Francisco, CA
Leadership
Cyrus Harmon
(Member of the Board)CEO of computational biotechnology company Vilya. Earned a PhD in Molecular and Cell Biology from University of California, Berkeley. Previously VP of Computational Genomics at Affymetrix.
Peter Kushner
(Chief Scientific Officer)Earned a PhD in Molecular Biology from the University of Oregon. Has been a Professor Emeritus at the University of California since 1986.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job
View 1 more job at Olema Oncology